The changing face of diabetes complications

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 6, 2016, Pages 537-547

  Gregg, Edward W ^a   Sattar, Naveed ^b   Ali, Mohammed K ^a,c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPUTATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; END STAGE RENAL DISEASE; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LEG AMPUTATION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES; COMPLICATION; EARLY DIAGNOSIS;

DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; HUMANS; PREVALENCE; UNITED STATES;

EID: 84968754775     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(16)30010-9     Document Type: Review

References (132)

1. IDF Diabetes Atlas 2015, International Diabetes Federation, International Diabetes Federation, Brussels, Belgium. 7 ed.
2. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014, 2:56-64.
3. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103:137-149.
4. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011, 378:31-40.
5. King H, Aubert RE, Herman WH Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998, 21:1414-1431.
6. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006, 29:2114-2116.
7. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 2011, 40:804-818.
8. Hwang CK, Han PV, Zabetian A, Ali MK, Narayan KM Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: a systematic review and meta-analysis. Diabetes Res Clin Pract 2012, 96:271-285.
9. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L The many faces of diabetes: a disease with increasing heterogeneity. Lancet 2014, 383:1084-1094.
10. Nathan DM Long-term complications of diabetes mellitus. N Engl J Med 1993, 328:1676-1685.
11. Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD ABC of arterial and venous disease: vascular complications of diabetes. BMJ 2000, 320:1062-1066.
12. Gerstein HC, Werstuck GH Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol 2013, 1:71-88.
13. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364:829-841.
14. Nathan DM Diabetes: advances in diagnosis and treatment. JAMA 2015, 314:1052-1062.
15. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med 2013, 368:1613-1624.
16. Stone MA, Charpentier G, Doggen K, et al. Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study. Diabetes Care 2013, 36:2628-2638.
17. Mudaliar U, Kim WC, Kirk K, Rouse C, Narayan KM, Ali M Are recommended standards for diabetes care met in Central and South America? A systematic review. Diabetes Res Clin Pract 2013, 100:306-329.
18. Sobngwi E, Ndour-Mbaye M, Boateng KA, et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract 2012, 95:30-36.
19. Gakidou E, Mallinger L, Abbott-Klafter J, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ 2011, 89:172-183.
20. Chuang LM, Tsai ST, Huang BY, Tai TY The status of diabetes control in Asia-a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998. Diabet Med 2002, 19:978-985.
21. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009, 301:2129-2140.
22. Lu FP, Lin KP, Kuo HK Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One 2009, 4:e4144.
23. Carstensen B, Jorgensen ME, Friis S The epidemiology of diabetes and cancer. Curr Diabetes Rep 2014, 14:535.
24. Wild S, Roglic G, Green A, Sicree R, King H Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
25. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015, 386:743-800.
26. Whiting DR, Guariguata L, Weil C, Shaw J IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011, 94:311-321.
27. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014, 2:634-647.
28. Kannel WB, McGee DL Diabetes and cardiovascular disease. The Framingham study. JAMA 1979, 241:2035-2038.
29. Reiber GE, Boyko EJ, Smith DG Lower extremity foot ulcers and amputations in diabetes. Diabetes in America 1995, 409-428. National Institutes of Health, Bethesda. 2nd edn. M.I. Harris (Ed.).
30. Klein RK, Boyko EJ Vision disorders in diabetes. Diabetes in America 1995, 293-338. National Institutes of Health. 2nd edn. M.I. Harris (Ed.).
31. National Diabetes Surveillance System Centers for Disease Control and Prevention, (accessed April 26, 2016). http://www.cdc.gov/diabetes/statistics/index.htm.
32. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med 2014, 370:1514-1523.
33. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study. Lancet Diabetes Endocrinol 2014, 2:867-874.
34. Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA 2004, 292:2495-2499.
35. Yashkin AP, Picone G, Sloan F Causes of the change in the rates of mortality and severe complications of diabetes mellitus: 1992-2012. Med Care 2015, 53:268-275.
36. Bethel MA, Sloan FA, Belsky D, Feinglos MN Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Int Med 2007, 167:921-927.
37. Carson AP, Tanner RM, Yun H, et al. Declines in coronary heart disease incidence and mortality among middle-aged adults with and without diabetes. Ann Epidemiol 2014, 24:581-587.
38. Preis SR, Hwang SJ, Coady S, et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009, 119:1728-1735.
39. Moxey PW, Gogalniceanu P, Hinchliffe RJ, et al. Lower extremity amputations-a review of global variability in incidence. Diabet Med 2011, 28:1144-1153.
40. Jorgensen ME, Almdal TP, Faerch K Reduced incidence of lower-extremity amputations in a Danish diabetes population from 2000 to 2011. Diabet Med 2014, 31:443-447.
41. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008, 51:2187-2196.
42. Harding JL, Shaw JE, Peeters A, Guiver T, Davidson S, Magliano DJ Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997-2010. Diabetes Care 2014, 37:2579-2586.
43. Lind M, Garcia-Rodriguez LA, Booth GL, et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 2013, 56:2601-2608.
44. Lipscombe LL, Hux JE Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
45. Booth GL, Hux JE, Fang J, Chan BT Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada. Diabetes Care 2005, 28:1045-1050.
46. Kennon B, Leese GP, Cochrane L, et al. Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care 2012, 35:2588-2590.
47. Lopez-de-Andres A, Martinez-Huedo MA, Carrasco-Garrido P, Hernandez-Barrera V, Gil-de-Miguel A, Jimenez-Garcia R Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008. Diabetes Care 2011, 34:1570-1576.
48. Vamos EP, Bottle A, Edmonds ME, Valabhji J, Majeed A, Millett C Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008. Diabetes Care 2010, 33:2592-2597.
49. Vamos EP, Millett C, Parsons C, Aylin P, Majeed A, Bottle A Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004-2009. Diabetes Care 2012, 35:265-272.
50. Ikonen TS, Sund R, Venermo M, Winell K Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study. Diabetes Care 2010, 33:2598-2603.
51. Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J 2008, 29:1889-1895.
52. Booth GL, Kapral MK, Fung K, Tu JV Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 2006, 29:32-37.
53. Boulton AJ, Vinik AI, Arezzo JC, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005, 28:956-962.
54. van Houtum WH, Rauwerda JA, Ruwaard D, Schaper NC, Bakker K Reduction in diabetes-related lower-extremity amputations in The Netherlands: 1991-2000. Diabetes Care 2004, 27:1042-1046.
55. Lombardo FL, Maggini M, De Bellis A, Seghieri G, Anichini R Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010. PloS One 2014, 9:e86405.
56. Rasmussen BS, Yderstraede KB, Carstensen B, Skov O, Beck-Nielsen H Substantial reduction in the number of amputations among patients with diabetes: a cohort study over 16 years. Diabetologia 2016, 59:121-129.
57. Kurowski JR, Nedkoff L, Schoen DE, Knuiman M, Norman PE, Briffa TG Temporal trends in initial and recurrent lower extremity amputations in people with and without diabetes in Western Australia from 2000 to 2010. Diabetes Res Clin Pract 2015, 108:280-287.
58. Buckley CM, O'Farrell A, Canavan RJ, et al. Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the Republic of Ireland. PLoS One 2012, 7:e41492.
59. Winell K, Venermo M, Ikonen T, Sund R Indicators for comparing the incidence of diabetic amputations: a nationwide population-based register study. Eur J Vasc Endovasc Surg 2013, 46:569-574.
60. Schofield CJ, Yu N, Jain AS, Leese GP Decreasing amputation rates in patients with diabetes-a population-based study. Diabet Med 2009, 26:773-777.
61. Krishnan S, Nash F, Baker N, Fowler D, Rayman G Reduction in diabetic amputations over 11 years in a defined U.K. population: benefits of multidisciplinary team work and continuous prospective audit. Diabetes Care 2008, 31:99-101.
62. Trautner C, Haastert B, Mauckner P, Gatcke LM, Giani G Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990-2005: results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 2007, 30:2633-2637.
63. Larsson J, Eneroth M, Apelqvist J, Stenstrom A Sustained reduction in major amputations in diabetic patients: 628 amputations in 461 patients in a defined population over a 20-year period. Acta Orthop 2008, 79:665-673.
64. Almaraz MC, Gonzalez-Romero S, Bravo M, et al. Incidence of lower limb amputations in individuals with and without diabetes mellitus in Andalusia (Spain) from 1998 to 2006. Diabetes Res Clin Prac 2012, 95:399-405.
65. Karpati T, Cohen-Stavi CJ, Leibowitz M, Hoshen M, Feldman BS, Balicer RD Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel. Popul Health Metr 2014, 12:32.
66. Li HY, Jiang YD, Chang CH, Chung CH, Lin BJ, Chuang LM Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000-2009. J Formos Med Assoc 2012, 111:645-650.
67. Goldberger N, Applbaum Y, Meron J, Haklai Z High Israeli mortality rates from diabetes and renal failure-can international comparison of multiple causes of death reflect differences in choice of underlying cause?. Isr J Health Policy Res 2015, 4:31.
68. Gregg EW, Cheng YJ, Saydah S, et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey. Diabetes Care 2012, 35:1252-1257.
69. Dale AC, Vatten LJ, Nilsen TI, Midthjell K, Wiseth R Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study. BMJ 2008, 337:a236.
70. Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 2015, 373:1720-1732.
71. Magliano DJ, Soderberg S, Zimmet PZ, et al. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010, 33:1983-1989.
72. Hennis AJ, Fraser HS, Jonnalagadda R, Fuller J, Chaturvedi N Explanations for the high risk of diabetes-related amputation in a Caribbean population of black african descent and potential for prevention. Diabetes Care 2004, 27:2636-2641.
73. Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001, 44(suppl 2):S65-S71.
74. Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F Global complication rates of type 2 diabetes in Indigenous peoples: A comprehensive review. Diabetes Res Clin Pract 2008, 82:1-17.
75. 2011 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States 2011, U.S. Renal Data System, USRDS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda.
76. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet 2013, 382:260-272.
77. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35:556-564.
78. Claessen H, Genz J, Bertram B, et al. Evidence for a considerable decrease in total and cause-specific incidences of blindness in Germany. Eur J Epidemiol 2012, 27:519-524.
79. Skaat A, Chetrit A, Belkin M, Kinori M, Kalter-Leibovici O Time trends in the incidence and causes of blindness in Israel. Am J Ophthalmol 2012, 153:214-221.
80. Wang J, Imai K, Engelgau MM, Geiss LS, Wen C, Zhang P Secular trends in diabetes-related preventable hospitalizations in the United States, 1998-2006. Diabetes Care 2009, 32:1213-1217.
81. Wang J, Williams DE, Narayan KM, Geiss LS Declining death rates from hyperglycemic crisis among adults with diabetes, US, 1985-2002. Diabetes Care 2006, 29:2018-2022.
82. Klafke A, Duncan BB, Stevens A, et al. The decline in mortality due to acute complications of diabetes mellitus in Brazil, 1991-2010. BMC Public Health 2015, 15:772.
83. Wang J, Geiss LS, Williams DE, Gregg EW Trends in Emergency department visit rates for hypoglycemia and hyperglycemic crisis among adults with diabetes, United States, 2006-2011. PLoS One 2015, 10:e0134917.
84. Woodward M, Zhang X, Barzi F, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003, 26:360-366.
85. Jarrett RJ, Keen H The WHO multinational study of vascular disease in diabetes: 3. Microvascular disease. Diabetes Care 1979, 2:196-201.
86. Keen H, Jarrett RJ The WHO multinational study of vascular disease in diabetes: 2. Macrovascular disease prevalence. Diabetes Care 1979, 2:187-195.
87. Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther 2010, 12:755-761.
88. Karter AJ, Ferrara A, Liu JY, Moffet HH, Ackerson LM, Selby JV Ethnic disparities in diabetic complications in an insured population. JAMA 2002, 287:2519-2527.
89. Kanaya AM, Adler N, Moffet HH, et al. Heterogeneity of diabetes outcomes among asians and pacific islanders in the US: the diabetes study of northern california (DISTANCE). Diabetes Care 2011, 34:930-997.
90. Li J, Dong Y, Wu T, Tong N Differences between western and Asian type 2 diabetes patients in the incidence of vascular complications and mortality: a systematic review of randomized controlled trials on lowering blood glucose. J Diabetes 2015, published online Dec 11. http://dx.doi.org/10.1111/1753-0407.12361.
91. Imperatore G, Cadwell BL, Geiss L, et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 2004, 160:531-539.
92. Wang J, James C, Gregg EW, Geiss L Changes in blood pressure among US adults with diabetes, 1988-2008. Diabetes Care 2011, 34:1579-1581.
93. Ford ES Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: findings from the National Health and Nutrition Examination Survey 1999-2008. J Diabetes 2011, 3:337-347.
94. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:7-22. Heart Protection Study Collaborative Group.
95. Fan AZ, Rock V, Zhang X, Li Y, Elam-Evans L, Balluz L Trends in cigarette smoking rates and quit attempts among adults with and without diagnosed diabetes, United States, 2001-2010. Prev Chronic Dis 2013, 10:E160.
96. Gu Q, Burt VL, Dillon CF, Yoon S Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010. Circulation 2012, 126:2105-2114.
97. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Int Med 2011, 171:404-410.
98. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007, 115:114-126.
99. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014, 63:2889-2934.
100. Gudbjornsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). Diabet Med 2009, 26:53-60.
101. Jahangiri-Noudeh Y, Akbarpour S, Lotfaliany M, et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. PLoS One 2014, 9:e112639.
102. Charlton J, Latinovic R, Gulliford MC Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study. Diabetes Care 2008, 31:1761-1766.
103. Tomlin AM, Dovey SM, Tilyard MW Patient outcomes from 10 years of annual diabetes reviews in New Zealand. Diabetes Res Clin Pract 2013, 102:129-137.
104. Thomsen RW, Baggesen LM, Svensson E, et al. Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study. Diabetes Obes Metab 2015, 17:771-780.
105. Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol 2015, 3:105-113.
106. Selvin E, Lazo M, Chen Y, et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation 2014, 130:1374-1382.
107. Ali MK, Bullard KM, Gregg EW, Del Rio C A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med 2014, 161:681-689.
108. Kahn SE, Cooper ME, Del Prato S Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 2013, 383:1068-1083.
109. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015, 373:2117-2128.
110. Ali MK, McKeever Bullard K, Imperatore G, Barker L, Gregg EW Characteristics associated with poor glycemic control among adults with self-reported diagnosed diabetes-National Health and Nutrition Examination Survey, United States, 2007-2010. MMWR Suppl 2012, 61:32-37.
111. Stringhini S, Tabak AG, Akbaraly TN, et al. Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 2012, 345:e5452.
112. Thomsen RW, Baggesen LM, Svensson E, et al. Early glycaemic control among patients with type 2 diabetes and initial glucose-lowering treatment: a 13-year population-based cohort study. Diabetes Obes Metab 2015, 17:771-780.
113. Looker HC, Nyangoma SO, Cromie DT, et al. Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia 2013, 56:1716-1725.
114. Case A, Deaton A Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci USA 2015, 112:15078-15083.
115. Burrows NR, Li Y, Geiss LS Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline. Diabetes Care 2010, 33:73-77.
116. Desai JR, Vazquez-Benitez G, Xu Z, et al. Who must we target now to minimize future cardiovascular events and total mortality? Lessons from the surveillance, prevention and management of diabetes mellitus (SUPREME-DM) cohort study. Circ Cardiovasc Qual Outcomes 2015, 8:508-516.
117. Harron KL, Feltbower RG, McKinney PA, Bodansky HJ, Campbell FM, Parslow RC Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0-29 years in West Yorkshire, UK, 1991-2006. Diabetes Care 2011, 34:652-654.
118. Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014, 311:1778-1786.
119. Imperatore G, Boyle JP, Thompson TJ, et al. Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012, 35:2515-2520.
120. Logue J, Walker JJ, Colhoun HM, et al. Do men develop type 2 diabetes at lower body mass indices than women?. Diabetologia 2011, 54:3003-3006.
121. Constantino MI, Molyneaux L, Limacher-Gisler F, et al. Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013, 36:3863-3869.
122. Tryggestad JB, Willi SM Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial. J Diabetes Complications 2015, 29:307-312.
123. Dart AB, Martens PJ, Rigatto C, Brownell MD, Dean HJ, Sellers EA Earlier onset of complications in youth with type 2 diabetes. Diabetes Care 2014, 37:436-443.
124. Chan JC, Lau ES, Luk AO, et al. Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis. Am J Med 2014, 127:616-624.
125. Saydah S, Bullard KM, Imperatore G, Geiss L, Gregg EW Cardiometabolic risk factors among US adolescents and young adults and risk of early mortality. Pediatrics 2013, 131:e679-e686.
126. Bardenheier BH, Lin J, Zhuo X, et al. Disability-free life-years lost among adults aged ≥50 years, with and without diabetes. Diabetes Care 2015, publsihed online Dec 30. http://dx.doi.org/10.2337/dc15-1095.
127. Huo X, Gao L, Guo L, et al. Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol 2016, 4:115-124.
128. Kalyani RR, Corriere M, Ferrucci L Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014, 2:819-829.
129. McMurray JJ, Gerstein HC, Holman RR, Pfeffer MA Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. Lancet Diabetes Endocrinol 2014, 2:843-851.
130. Zhuo X, Zhang P, Barker L, Albright A, Thompson TJ, Gregg E The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care 2014, 37:2557-2564.
131. Wong E, Backholer K, Gearon E, et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013, 1:106-114.
132. Lin WH, Hsu CH, Chen HF, Liu CC, Li CY Mortality of patients with type 2 diabetes in Taiwan: a 10-year nationwide follow-up study. Diabetes Res Clin Pract 2015, 107:178-186.